BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  BLINCYTO® (BLINATUMOMAB) ADDED TO CONSOLIDATION CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN ADULT PATIENTS WITH MEASURABLE RESIDUAL DISEASE-NEGATIVE B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

  Amgen (NASDAQ: AMGN) today announced the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present results from the E1910 randomized Phase 3 trial.

  December 13, 2022

   · 

  24 min read
• Biotech Beach

  Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - December 13, 2022

  Mirati Therapeutics, Inc. announced that the company granted equity awards to 11 new employees with a grant date of December 1, 2022, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

  December 13, 2022

   · 

  3 min read
• Business

  Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter 2022 Results

  Johnson & Johnson will host a conference call for investors at 8:30 a.m. on Tuesday, January 24th to review fourth-quarter results.

  December 13, 2022

   · 

  2 min read
• Biotech Bay

  Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio

  Astellas Venture Management LLC (President: William Watt, Ph.D., “AVM”) and Mission BioCapital BioLabs (“MBC BioLabs”) today announced Bespoke Biotherapeutics and Cellinfinity Bio as the winners of the Astellas-sponsored “Future Innovator Prize” at MBC BioLabs.

  December 13, 2022

   · 

  7 min read